Interpretative reading of susceptibility results is very important, such as in the phenotypic detection of resistance mechanisms such as ESBLs and carbapenemases. Microbiologists should be aware of new EUCAST definitions of I. There are also newer recommended tests to detect colistin resistance. For multidrug resistant organisms, testing of antimicrobial combinations may be needed. Laboratories should be alert for detection of new resistance mechanisms.

Presenter: Professor: Emilia Cercenado, Pharm.D.

Professor Emilia Cercenado is the staff senior specialist in microbiology and parasitology at Hospital General Universitario Gregorio Marañón in Madrid, Spain, and an associate professor of microbiology at the Complutense University, also in Madrid. Professor. Cercenado has a Pharm. D. and has held a research fellow position at the University of California at Los Angeles and Harvard Medical School. Professor. Cercenado has co-authored over 340 publications and serves as associate editor of Enfermedades Infecciosas y Microbiologia Clinica, and as editor of Microbiological Procedures in Clinical Microbiology, of the Spanish Society of Infectious Diseases and Clinical Microbiology. She is also a member of the scientific advisory group of the Spanish Agency of Medicines and the European Medicines Agency for antimicrobials. Furthermore, Professor. Cercenado is a technical auditor for clinical laboratories of the Entidad Nacional de Acreditación in Spain.